Analysis of HCMV Infection of Monocytes and Macrophages

单核细胞和巨噬细胞的HCMV感染分析

基本信息

  • 批准号:
    7216833
  • 负责人:
  • 金额:
    $ 27.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-04-01 至 2009-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Human cytomegalovirus (HCMV) causes severe disease in the immunocompromised (AIDS and transplant patients, and neonates). It is also associated with chronic human diseases in the immunocompetent. A critical feature of HCMV infections is the hematogenous dissemination of the virus that is central to disease pathogenesis. HCMV viremia is cell-associated, but the cell type responsible has not been conclusively identified. Monocytes are likely candidates to mediate viral dissemination. Monocytes are the primary cell type infected in the blood and are the predominant infiltrating cell type found in infected organs. The problem is that monocytes are not productively infected by HCMV; virus replication is abortive. Macrophages (differentiate from monocytes) support productive viral replication and infected macrophages are found in multiple tissues in HCMV patients. However, they are not blood-borne cells and cannot be responsible for hematogenous spread. Thus, current findings are contradictory and the cell type involved in HCMV spread remains unresolved. We propose a solution to this apparent conundrum and that is, that HCMV infection of monocytes drives their specific migration out of the blood into peripheral tissues, where they can differentiate into macrophages and can then replicate the original virus carried from the blood into the tissue by the infected monocytes. Therefore, we suggest that HCMV possesses the ability to drive extravasation and monocyte-to-macrophage differentiation and that this is a critical function of the virus. We have preliminary data to support this proposal. To our knowledge, a precedent for this strategy in other viruses has not been reported and it is consistent with what is known about HCMV pathogenesis. We hypothesize that HCMV induces extravasation of monocytes to peripheral tissues and their differentiation into productively infected macrophages. The specific aims are as follows: 1) to investigate if viral binding initiates monocyte-to-macrophage differentiation and the role of HCMV infection in monocyte extravasation; 2) to examine viral gene expression and replication in viral differentiated macrophages; and, 3) to determine the molecular signaling mechanisms associated with the viral-induced differentiation of monocytes into macrophages. Overall, this proposal investigates the mechanisms involved in HCMV spread and persistence.
描述(申请人提供):人类巨细胞病毒(HCMV)在免疫功能低下的人(艾滋病和移植患者,以及新生儿)中会导致严重疾病。它还与人类慢性疾病中的免疫活性有关。巨细胞病毒感染的一个关键特征是病毒的血源性传播,这是疾病发病机制的核心。人巨细胞病毒病毒血症与细胞相关,但细胞类型尚未确定。单核细胞可能是介导病毒传播的候选细胞。单核细胞是血液中感染的主要细胞类型,也是感染器官中发现的主要浸润性细胞类型。问题是,单核细胞不能有效地感染HCMV;病毒复制是流产的。巨噬细胞(从单核细胞分化而来)支持病毒的高效复制,在HCMV患者的多个组织中发现感染的巨噬细胞。然而,它们不是血液传播的细胞,不能负责血源性传播。因此,目前的发现是相互矛盾的,涉及到HCMV传播的细胞类型仍然没有解决。我们提出了一种解决这一难题的方法,即单核细胞感染巨细胞病毒,促使它们特异性地从血液中迁移到周围组织,在那里它们可以分化为巨噬细胞,然后可以通过感染的单核细胞将原始病毒从血液中复制到组织中。因此,我们认为HCMV具有驱动外渗和单核细胞向巨噬细胞分化的能力,这是病毒的关键功能。我们有初步数据支持这一提议。据我们所知,这一策略在其他病毒中的先例尚未报道,这与已知的关于HCMV发病机制的情况是一致的。我们推测,巨细胞病毒可诱导单核细胞向外周组织渗出,并分化为可产生感染的巨噬细胞。其具体目的如下:1)研究病毒结合是否启动单核细胞向巨噬细胞的分化以及巨细胞病毒感染在单核细胞外渗中的作用;2)检测病毒基因在病毒分化的巨噬细胞中的表达和复制;3)确定病毒诱导单核细胞向巨噬细胞分化的分子信号机制。总体而言,这项建议调查了人巨细胞病毒传播和持续的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDREW D YUROCHKO其他文献

ANDREW D YUROCHKO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDREW D YUROCHKO', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10090769
  • 财政年份:
    2021
  • 资助金额:
    $ 27.5万
  • 项目类别:
Center for Applied Immunology and Pathological Processes
应用免疫学和病理过程中心
  • 批准号:
    10090768
  • 财政年份:
    2021
  • 资助金额:
    $ 27.5万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10569051
  • 财政年份:
    2021
  • 资助金额:
    $ 27.5万
  • 项目类别:
Center for Applied Immunology and Pathological Processes
应用免疫学和病理过程中心
  • 批准号:
    10360457
  • 财政年份:
    2021
  • 资助金额:
    $ 27.5万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10360458
  • 财政年份:
    2021
  • 资助金额:
    $ 27.5万
  • 项目类别:
Center for Applied Immunology and Pathological Processes
应用免疫学和病理过程中心
  • 批准号:
    10569050
  • 财政年份:
    2021
  • 资助金额:
    $ 27.5万
  • 项目类别:
HCMV regulation of host cell signaling and cytokines in myelosuppression
HCMV 在骨髓抑制中对宿主细胞信号传导和细胞因子的调节
  • 批准号:
    9980285
  • 财政年份:
    2017
  • 资助金额:
    $ 27.5万
  • 项目类别:
HCMV regulation of host cell signaling and cytokines in myelosuppression
HCMV 在骨髓抑制中对宿主细胞信号传导和细胞因子的调节
  • 批准号:
    10216638
  • 财政年份:
    2017
  • 资助金额:
    $ 27.5万
  • 项目类别:
HCMV regulation of monocyte/macrophage host cell signaling in viral reactivation
HCMV 对病毒再激活中单核细胞/巨噬细胞宿主细胞信号传导的调节
  • 批准号:
    10327952
  • 财政年份:
    2017
  • 资助金额:
    $ 27.5万
  • 项目类别:
HCMV regulation of monocyte/macrophage host cell signaling in viral reactivation
HCMV 对病毒再激活中单核细胞/巨噬细胞宿主细胞信号传导的调节
  • 批准号:
    10629186
  • 财政年份:
    2017
  • 资助金额:
    $ 27.5万
  • 项目类别:

相似海外基金

A lipid-induced RNA-binding protein in atherosclerosis
动脉粥样硬化中脂质诱导的 RNA 结合蛋白
  • 批准号:
    10363664
  • 财政年份:
    2020
  • 资助金额:
    $ 27.5万
  • 项目类别:
A lipid-induced RNA-binding protein in atherosclerosis
动脉粥样硬化中脂质诱导的 RNA 结合蛋白
  • 批准号:
    10586123
  • 财政年份:
    2020
  • 资助金额:
    $ 27.5万
  • 项目类别:
RNA-binding proteins in atherosclerosis
动脉粥样硬化中的 RNA 结合蛋白
  • 批准号:
    10375500
  • 财政年份:
    2018
  • 资助金额:
    $ 27.5万
  • 项目类别:
RNA-binding proteins in atherosclerosis
动脉粥样硬化中的 RNA 结合蛋白
  • 批准号:
    9888406
  • 财政年份:
    2018
  • 资助金额:
    $ 27.5万
  • 项目类别:
Functional analysis of ApoA-I/HDL binding protein for the treatment of atherosclerosis(Fostering Joint International Research)
ApoA-I/HDL结合蛋白治疗动脉粥样硬化的功能分析(促进国际联合研究)
  • 批准号:
    16KK0203
  • 财政年份:
    2017
  • 资助金额:
    $ 27.5万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research)
Development of diagnostic method for atherosclerosis targeting adipokine binding proteins
开发针对脂肪因子结合蛋白的动脉粥样硬化诊断方法
  • 批准号:
    15H04762
  • 财政年份:
    2015
  • 资助金额:
    $ 27.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of a novel IL18 binding protein in atherosclerosis
新型 IL18 结合蛋白在动脉粥样硬化中的作用
  • 批准号:
    8882740
  • 财政年份:
    2015
  • 资助金额:
    $ 27.5万
  • 项目类别:
Role of a novel IL18 binding protein in atherosclerosis
新型 IL18 结合蛋白在动脉粥样硬化中的作用
  • 批准号:
    9130248
  • 财政年份:
    2015
  • 资助金额:
    $ 27.5万
  • 项目类别:
Progranulin, a Novel HDL-Binding Protein, Suppresses Systemic Inflammation, Glucose Abnormality and Atherosclerosis
颗粒体蛋白前体是一种新型 HDL 结合蛋白,可抑制全身炎症、血糖异常和动脉粥样硬化
  • 批准号:
    24390233
  • 财政年份:
    2012
  • 资助金额:
    $ 27.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
S100A8/9 calcium binding proteins enhances myeloid cell proliferation and impairs atherosclerosis regression in diabetes
S100A8/9 钙结合蛋白增强骨髓细胞增殖并损害糖尿病患者的动脉粥样硬化消退
  • 批准号:
    252764
  • 财政年份:
    2012
  • 资助金额:
    $ 27.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了